Freshpaint

Ensures HIPAA compliance for digital analytics

San Francisco, California, United States

About Freshpaint

Freshpaint provides a solution for healthcare providers and related businesses to comply with HIPAA regulations, which protect patients' medical records and health information. Their main service replaces non-compliant tracking technologies with their own, ensuring that Protected Health Information (PHI) is not shared with advertising and analytics tools. This allows businesses to use existing tools like Google Analytics without risking HIPAA violations. Freshpaint operates in a niche market, focusing on the intersection of digital analytics and healthcare privacy, and likely uses a subscription or usage-based fee model to generate revenue while helping clients maintain compliance.

San Francisco, CaliforniaHeadquarters
2019Year Founded
$38.6MTotal Funding
SERIES_BCompany Stage
Data & Analytics, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Unlimited Paid Time Off
Mental Health Support
Gym Membership
Generous Parental Leave
Flexible Work Hours
Company Equity
Remote Work Options

Risks

Potential changes in HIPAA regulations could require costly platform updates.
Increased competition may erode Freshpaint's market share.
Rapid technological advancements may outpace Freshpaint's integration capabilities.

Differentiation

Freshpaint offers HIPAA-compliant analytics solutions for healthcare providers.
The platform integrates marketing tools with one click, simplifying data management.
Freshpaint replaces non-compliant tracking technologies, ensuring patient data privacy.

Upsides

Freshpaint raised $30.7M in Series B funding to expand its platform.
Partnerships with Invoca and Stackadapt enhance privacy-compliant advertising capabilities.
Increased demand for privacy-compliant analytics in healthcare boosts Freshpaint's market potential.

Funding

Total raised$38.57 M
Latest valuation$150.00 M
StageSERIES_B
DEBT
10/31/2022
$5
SERIES A
10/31/2022
$10
$47.50 M
SEED
2/29/2020
N/A
$750.0 K